Envoy Medical COCH Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | -310.7%-26.2pp | -262.7%-32.9pp | -294.2%-99.6pp | -262.2%-90.3pp | -284.4%-136pp | |
| Operating margin | -9,881.2%-693pp | -9,240.7%-682pp | -9,824%-2,115pp | -8,873%-2,302pp | -9,188.7%-2,632pp | |
| Net margin | -9,875.6%-667pp | -9,857.3%-615pp | -10,475%-2,895pp | -9,579.3%-5,093pp | -9,209%-1,485pp | |
| Efficiency | ||||||
| Asset turnover | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Liquidity | ||||||
| Current ratio | 2.3×+1.2× | 0.5×-0.6× | 0.6×-0.1× | 0.9×+0.3× | 1.1×0.0× | |
| Per Share | ||||||
| Book value per share | $0.15+113% | -$0.52+47.9% | -$0.35+64.8% | -$1.40-109% | -$1.14-184% | |
| Valuation | ||||||
| Market capitalization | $61M+83.5% | $19.13M-33.9% | $18.47M-71.0% | $30.28M-34.5% | $27.68M-64.0% | |
| Price / sales | 260.7×+111× | 79.4×-49.3× | 88.8×-140× | 136.4×-16.8× | 130.6×-128× | |
| Price / book | 5.7×— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Envoy Medical's profit margins?
- Envoy Medical (COCH) runs a -310.7% gross margin and a -9881.2% operating margin, with a -9875.6% net margin.
- Where do Envoy Medical's ratios come from?
- Every ratio is computed from Envoy Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
